Zhejiang Ausun Pharmaceutical (603229.SH) controlling shareholder proposed to repurchase company's shares with an amount ranging from 50 million yuan to 100 million yuan.

Zhejiang Ausun Pharmaceutical (603229.SH) issued an announcement. The Board of Directors received a letter from the company's controlling shareholder, actual controller, and Chairman and General Manager Mr. Zheng Zhiguo on January 14, 2025, proposing to repurchase the company's shares. Mr. Zheng Zhiguo proposed that the company repurchase a portion of its RMB ordinary shares (A shares) through the Shanghai Stock Exchange trading system in a centralized bidding trading method. The total amount of funds for the repurchase shall not be less than 50 million yuan, and not more than 100 million yuan. The repurchased shares are intended to be used in the future for implementing equity incentives and/or employee stock ownership plans.